SATELLITE SYMPOSIA

• Explore the disease burden and life-long impact in children with uncontrolled atopic dermatitis (AD)
• Discuss the importance of targeting type 2 inflammation in childhood, with a focus on skin barrier normalization, and implications for disease course modification
• Review emerging clinical and real-world data supporting early intervention in reducing the life-long impact of AD

12:25
Welcome - Michael J. Cork (Chair)

12:35
Beyond the Signs and Symptoms: The Developmental Burden of Atopic Dermatitis (AD) in Children - Pablo Coto Segura

12:45
Targeting Type 2 Inflammation: Skin Barrier Normalization - Michael J. Cork

12:55
Early Intervention in AD: Latest Clinical and Real-world Data - Michele Ramien

13:10

Closing polling questions (5 mins), Roundtable discussion / Q&A (10 mins)